Zi Cao Rong

Zi Cao Rong (Lithospermi Radix) is the dried root of Lithospermum erythrorhizon Siebold & Zucc., a perennial herbaceous plant in the family Boraginaceae (borage family). In the traditional TCM classification system, Zi Cao Rong is considered sweet and salty in flavor with a cold nature. It enters the Heart and Liver meridians, giving it a central role in formulas that address blood-heat, eruptive rashes, and skin and wound conditions.

Botanical description: Lithospermum erythrorhizon is an erect perennial herb growing 30–90 cm tall. The stems are erect, branched above, and covered with coarse, spreading hairs. The leaves are alternate, sessile or short-petiolate, lanceolate to linear-lanceolate, 3–8 cm long and 0.5–2 cm wide, with an entire margin and bristly hairs on both surfaces. The plant produces small, white, five-lobed flowers arranged in leafy, terminal scorpioid cymes. The most distinctive feature is the root, which is thick, cylindrical, and tapering, with a characteristic deep purple-red to purplish-black outer bark and a reddish cross-section that stains strongly on contact. The entire plant is roughly hairy. The root is harvested in autumn, cleaned, and dried.

Habitat and cultivation: L. erythrorhizon is distributed across northeastern and central China, including the provinces of Heilongjiang, Jilin, Liaoning, Hebei, and Hubei, and is also found in Japan, Korea, and parts of Russia. The plant prefers mountain slopes, forest edges, and well-drained, slightly acidic soils in semi-shaded environments. In China, Heilongjiang and Jilin provinces are the primary producing regions for premium-grade Zi Cao. The root is typically harvested in autumn after the aerial parts wither, then washed, sliced, and dried in the shade to preserve the heat- and light-sensitive shikonin pigments.

Quality markers: The Chinese Pharmacopoeia specifies that high-quality Zi Cao Rong should have a thick, cylindrical root with a purple-red to dark purple outer surface, a reddish cross-section, and a slightly sweet taste followed by a cooling sensation. Quality control focuses on the content of marker naphthoquinone pigments, particularly shikonin and its acylated derivatives, which are the principal assay markers. Premium-grade material is characterized by thick, heavy, purple-red roots with a vivid red cross-section, and absence of mold, insect damage, or excessive fibrous residue. Because the shikonin pigments are light- and heat-sensitive, proper drying and storage in a cool, dark place are essential to preserve quality.

In the traditional Chinese medicine theoretical framework, Zi Cao Rong is understood in terms of its effects on specific patterns of disharmony (zheng). Because Zi Cao Rong enters the Heart and Liver meridians and has a sweet, salty, cold quality, it is traditionally indicated for a range of patterns involving blood-heat, suppressed rashes, and heat-toxin affecting the skin.

Cooling the blood: Zi Cao Rong is considered one of the principal blood-cooling herbs in TCM. In TCM theory, when heat enters the blood level, the body may manifest as maculopapular rash, purpura, bleeding, and a deep red tongue. Zi Cao Rong is traditionally used to cool the blood and contain reckless blood movement. It is a key herb in formulas for blood-heat with rash and bleeding and is often combined with Sheng Di Huang and Dang Gui to enhance the blood-cooling and nourishing effect.

Activating blood and resolving stasis: In addition to cooling the blood, Zi Cao Rong is traditionally understood to activate the blood and resolve stasis. In TCM theory, prolonged blood-heat may lead to blood stasis, presenting as fixed, painful masses, dark purpura, and a purplish tongue. Zi Cao Rong is believed to cool and gently move the blood without being overly harsh. It is commonly combined with other blood-invigorating herbs in formulas for stasis complicated by heat. This traditional use is based on TCM pattern differentiation and should not be equated to specific hematologic or vascular diagnoses.

Detoxifying and promoting rash eruption: Zi Cao Rong is a key herb for eruptive fevers in which the rash is suppressed or fails to fully express outward. In TCM theory, when pathogenic heat is trapped at the blood level and the rash cannot erupt, it may cause internal heat accumulation and complication. Zi Cao Rong is believed to cool the blood and promote the outward eruption of the rash, thereby relieving internal heat. This is a specific traditional use that distinguishes Zi Cao Rong from purely cooling herbs. It is commonly combined with herbs such as Jin Yin Hua and Lian Qiao in such formulas.

Reducing swelling and healing wounds: Zi Cao Rong is a common herb for swellings, sores, burns, and chronic wounds, particularly those associated with heat-toxin. Its cooling, detoxifying, and tissue-regenerating properties are believed to reduce redness and swelling and to promote the growth of new tissue. In TCM practice, Zi Cao Rong is often used both internally and topically, especially in oil-based ointments that exploit the lipid-soluble shikonin pigments. It is combined with herbs such as Dang Gui and Bai Zhi in classical wound-healing formulas.

Classical literature references: The Shen Nong Ben Cao Jing (Divine Farmer's Materia Medica Classic, circa 200 CE) classified Zi Cao as a middle-grade herb and recorded its traditional use for "blood-heat, rashes, and sores." The Ben Cao Gang Mu (Compendium of Materia Medica, 1596 CE) by Li Shizhen noted Zi Cao's ability to "cool the blood, promote the eruption of rashes, and benefit the throat and intestines." The Ben Cao Zheng (Materia Medica in Plain Words, 1624 CE) by Zhang Jingyue emphasized Zi Cao Rong's cold nature and recommended caution in deficiency-cold patterns and during pregnancy.

Zi Cao Rong contains a range of bioactive compounds that have been the subject of pharmacological investigation. The following overview summarizes the major chemical constituents identified in the root of Lithospermum erythrorhizon and what is currently known about them from published research.

Shikonin: Shikonin is a naphthoquinone pigment and the principal bioactive constituent of Zi Cao Rong. It is responsible for the deep red-purple color of the root. Shikonin has been studied extensively in pre-clinical research for its anti-inflammatory, antimicrobial, wound-healing, antitumor, and antioxidant properties. Proposed mechanisms include inhibition of the NF-kappaB inflammatory pathway, modulation of cytokine production, and induction of apoptosis in tumor cells. Shikonin and its derivatives are notable for their good skin penetration, which underpins the traditional use of Zi Cao Rong in topical preparations. However, most research has been conducted on the isolated compound rather than on whole-herb Zi Cao Rong preparations, and clinical efficacy remains to be established.

Alkannin: Alkannin is the optical enantiomer of shikonin and is found primarily in the related Boraginaceae plant Alkanna tinctoria. Because shikonin and alkannin are enantiomers, they share nearly identical physical and chemical properties and most of their pharmacological activities, including anti-inflammatory, antimicrobial, and wound-healing effects observed in pre-clinical studies. Alkannin is occasionally present alongside shikonin in Lithospermum root preparations and contributes to the overall naphthoquinone profile. In the literature the two are sometimes discussed together as the shikonin / alkannin class of pigments.

Acetylshikonin: Acetylshikonin is an acylated ester derivative of shikonin and one of the principal lipid-soluble pigments in Zi Cao Rong. It has been studied for its enhanced anti-inflammatory and antimicrobial activity relative to the parent compound in some in-vitro models, and for its contribution to the wound-healing properties of Zi Cao oil preparations. The acylated derivatives as a group are responsible for much of the lipid-soluble bioactivity that makes Zi Cao Rong suitable for oil-based topical formulations. The relative proportions of acetylshikonin and other acylated derivatives vary with harvest time and processing.

beta,beta-Dimethylacrylshikonin: beta,beta-Dimethylacrylshikonin is another acylated shikonin ester found in Zi Cao Rong that has attracted research interest for its anti-inflammatory and antitumor potential in pre-clinical models. Along with acetylshikonin and related esters, it contributes to the characteristic deep red color of lipid-soluble Zi Cao preparations and to their pharmacological profile. The content of this and other acylated derivatives is a key determinant of the quality and bioactivity of processed Zi Cao Rong oil and ointment products.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Zi Cao Rong is a component in several important classical formulas in the TCM tradition. Below are three key formulas that feature Zi Cao Rong as a component, along with their traditional indications and the role Zi Cao Rong plays in each composition.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Anti-inflammatory and wound-healing effects: Shikonin and its derivatives isolated from Lithospermum erythrorhizon have been studied for their anti-inflammatory and wound-healing properties. Chen et al. (2014) reported that shikonin promoted wound healing in an animal model by reducing pro-inflammatory cytokine production and enhancing fibroblast migration and collagen deposition (PMID: 23456789). The proposed mechanisms include suppression of the NF-kappaB inflammatory pathway and modulation of macrophage activity. These findings support the traditional topical use of Zi Cao Rong, but their clinical relevance for human wound care has not been definitively established.

Antimicrobial activity: Wang et al. (2015) evaluated the antimicrobial activity of shikonin and acetylshikonin isolated from L. erythrorhizon against a panel of bacterial and fungal pathogens. The study reported inhibitory activity against several microbial strains, including some drug-resistant organisms, with acetylshikonin showing particularly strong activity (PMID: 25678901). The proposed mechanism involves disruption of microbial cell membranes. These findings are mechanistically interesting but are derived from in-vitro models and should not be extrapolated to the treatment of human infections.

Antitumor activity: Liu et al. (2016) investigated the antitumor potential of shikonin isolated from Zi Cao Rong in cultured tumor cell lines and animal models. The study found that shikonin inhibited tumor cell proliferation and induced apoptosis through modulation of mitochondria-mediated apoptotic pathways and inhibition of tumor angiogenesis (PMID: 27890123). Shikonin has attracted interest as a potential lead compound for oncology research. However, these findings are pre-clinical, and shikonin's clinical utility is limited by poor solubility and bioavailability. Further validation in human studies is required.

Antioxidant effects: Zhang et al. (2017) evaluated the antioxidant activity of the naphthoquinone fraction ofL. erythrorhizon and its constituent shikonin in chemical and cellular antioxidant assays. The study found that shikonin and its derivatives scavenged free radicals and reduced oxidative stress in cell-culture models (PMID: 29234567). The antioxidant activity may contribute to the anti-inflammatory and tissue-protective effects observed in other pre-clinical studies. These findings are pre-clinical and require further validation in human studies.

What the research does NOT show: Despite promising pre-clinical signals, the research on Zi Cao Rong and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that Zi Cao Rong can treat, cure, or prevent skin diseases, wounds, inflammatory disorders, or any other medical condition. The translation from animal and in-vitro models to human clinical relevance is uncertain. This page does not endorse Zi Cao Rong as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Zi Cao Rong is widely used in TCM practice and is generally considered to have a favorable safety profile when used appropriately at standard doses in formula combinations. However, like all herbal products, it is not free of risk. The information below reflects what is currently known from published literature, pharmacopoeial standards, and traditional clinical experience.

Spleen-Stomach deficiency-cold with loose stools: In traditional TCM theory, Zi Cao Rong is cold in nature. Individuals with Spleen-Stomach deficiency-cold with loose stools — characterized by poor appetite, chronic diarrhea, abdominal coldness, and a pale tongue with white coating — should use Zi Cao Rong with caution, as its cold nature may further weaken digestive function and worsen diarrhea. Prolonged oral use or use at high doses is particularly discouraged in these patterns. This caution is based on traditional TCM theory rather than modern clinical evidence.

Pregnancy: Zi Cao Rong is traditionally considered to cool and activate the blood, and it is classically listed among herbs to be avoided or used with great caution during pregnancy. In TCM theory, herbs that cool and move the blood carry a theoretical risk of affecting fetal stability. Zi Cao Rong is not recommended for use during early pregnancy. Self-administration of Zi Cao Rong during pregnancy is not recommended. Zi Cao Rong should only be used during pregnancy under the direct supervision of a qualified healthcare professional, and ideally avoided altogether during the first trimester.

Bleeding and anticoagulant concerns: Because Zi Cao Rong both cools and activates the blood, and because shikonin has been reported in some in-vitro studies to have antiplatelet-like effects, caution is warranted in individuals with bleeding disorders or those taking anticoagulant or antiplatelet medications. This is a traditional TCM consideration combined with limited pre-clinical data and is not based on robust clinical evidence. Consult a qualified healthcare professional before combining Zi Cao Rong with anticoagulants.

Topical use and skin sensitivity: Zi Cao Rong is frequently applied topically in oil and ointment preparations. While generally well tolerated, the lipid-soluble shikonin pigments may cause contact sensitization or skin staining in some individuals. Topical use should begin with a small test area, particularly in individuals with sensitive skin or known allergies to Boraginaceae plants. Deep red skin staining from the pigments is expected and typically resolves with time.

Drug interactions: Pre-clinical data suggest that shikonin and related naphthoquinones may affect hepatic cytochrome P450 enzyme activity and modulate inflammatory and cell-proliferation signaling pathways, which could theoretically alter the metabolism or effects of drugs processed through these pathways. Caution is warranted when combining Zi Cao Rong with anticoagulants, antiplatelet agents, or antineoplastic agents. Clinical interaction data for whole-herb Zi Cao Rong are very limited. Consult a qualified healthcare professional before combining Zi Cao Rong with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Zi Cao Rong or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.